Detalhe da pesquisa
1.
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Nature
; 600(7888): 319-323, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819663
2.
Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
Proc Natl Acad Sci U S A
; 118(27)2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140350
3.
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial.
Cancer Sci
; 114(8): 3342-3351, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139543
4.
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations.
Proc Natl Acad Sci U S A
; 116(20): 10025-10030, 2019 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043566
5.
Longitudinal Assessment of Prognostic Understanding in Patients with Advanced Lung Cancer and Its Association with Their Psychological Distress.
Oncologist
; 26(12): e2265-e2273, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34510654
6.
Trends of concerns from diagnosis in patients with advanced lung cancer and their family caregivers: A 2-year longitudinal study.
Palliat Med
; 35(5): 943-951, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761790
7.
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Lancet Oncol
; 20(5): 625-635, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975627
8.
Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 197(7): 885-896, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29211494
9.
Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers.
Oncologist
; 23(10): 1218-1229, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120158
10.
Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma.
Acta Neuropathol
; 127(5): 731-45, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240813
11.
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).
Eur J Cancer
; 197: 113469, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061214
12.
Calcium channel blockers may reduce the development of long COVID in females.
Hypertens Res
; 47(4): 934-943, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978232
13.
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid).
Clin Cancer Res
; 29(8): 1506-1514, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201167
14.
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination.
iScience
; 26(7): 107208, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37448563
15.
Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections.
Heliyon
; 9(3): e13795, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915486
16.
Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinations.
Vaccine X
; 15: 100381, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731516
17.
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force.
Open Forum Infect Dis
; 10(7): ofad311, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441355
18.
Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma.
Onco Targets Ther
; 15: 981-989, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36134388
19.
Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer.
JCO Oncol Pract
; 18(12): e1977-e1986, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346964
20.
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.
Lancet Respir Med
; 10(1): 72-82, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454653